Congenital Orbital Rhabdomyosarcoma

被引:3
作者
Eghtedari, Masoomeh [1 ]
Farsiani, Amir Reza [1 ]
Bordbar, Mohammad Reza [2 ]
机构
[1] Shiraz Univ Med Sci, Poostchi Ophthalmol Res Ctr, Dept Ophthalmol, Shiraz, Iran
[2] Shiraz Univ Med Sci, Hematol Res Ctr, Sch Med, Shiraz, Iran
关键词
Rhabdomyosarcoma; Orbit; Congenital tumor; Exenteration;
D O I
10.1159/000481533
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Rhabdomyosarcoma (RMS) is the most common malignant tumor of the orbit in children, but it is rarely present at birth. We report a large congenital orbital RMS with intracranial extension in a newborn baby. A newborn baby girl was referred to our hospital due to severe right-eye exophthalmia. Imaging studies showed an orbital mass with intracranial extension. Treatment was started with a course of neoadjuvant chemotherapy followed by right orbital exenteration and intracranial resection of the tumor. Histologic examination of the mass showed undifferentiated malignant small-cell tumor. Immunohistochemical study proved it to be RMS. The patient was categorized as intermediate-risk RMS and chemotherapy was continued accordingly with VAC regimen. In spite of treatment, the infant developed intracranial recurrence at the age of 6 months and died 1 month later. Congenital orbital RMS has a poor prognosis. Reconstruction surgery should be deferred due to high rate of recurrence and low chance of survival. A multidisciplinary approach might increase the survival of these patients. (C) 2017 S. Karger AG, Basel
引用
收藏
页码:165 / 169
页数:5
相关论文
共 8 条
[1]   Vincristine, Actinomycin, and Cyclophosphamide Compared With Vincristine, Actinomycin, and Cyclophosphamide Alternating With Vincristine, Topotecan, and Cyclophosphamide for Intermediate-Risk Rhabdomyosarcoma: Children's Oncology Group Study D9803 [J].
Arndt, Carola A. S. ;
Stoner, Julie A. ;
Hawkins, Douglas S. ;
Rodeberg, David A. ;
Hayes-Jordan, Andrea A. ;
Paidas, Charles N. ;
Parham, David M. ;
Teot, Lisa A. ;
Wharam, Moody D. ;
Breneman, John C. ;
Donaldson, Sarah S. ;
Anderson, James R. ;
Meyer, William H. .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (31) :5182-5188
[2]  
Chen B, 2007, CLIN OPHTHALMIC ONCO, P581
[3]  
Huh WW, 2011, MD ANDERSON SOLID TU, P61, DOI 10.1007/978-1-4419-0374-7_4
[4]   DEVELOPMENTAL ORIGINS OF FUSION-NEGATIVE RHABDOMYOSARCOMAS [J].
Kikuchi, Ken ;
Rubin, Brian P. ;
Keller, Charles .
CURRENT TOPICS IN DEVELOPMENTAL BIOLOGY: MYOGENESIS, 2011, 96 :33-56
[5]   Treatment of orbital rhabdomyosarcoma: Survival and late effects of treatment - Results of an international workshop [J].
Oberlin, O ;
Rey, A ;
Anderson, J ;
Carli, M ;
Raney, RB ;
Treuner, J ;
Stevens, MCG .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (01) :197-204
[6]   A Clinical Update and Radiologic Review of Pediatric Orbital and Ocular Tumors [J].
Rao, Ajay A. ;
Naheedy, John H. ;
Chen, James Y. -Y. ;
Robbins, Shira L. ;
Ramkumar, Hema L. .
JOURNAL OF ONCOLOGY, 2013, 2013
[7]   PROGNOSTIC FACTORS IN 951 NONMETASTATIC RHABDOMYOSARCOMA IN CHILDREN - A REPORT FROM THE INTERNATIONAL RHABDOMYOSARCOMA WORKSHOP [J].
RODARY, C ;
GEHAN, EA ;
FLAMANT, F ;
TREUNER, J ;
CARLI, M ;
AUQUIER, A ;
MAURER, H .
MEDICAL AND PEDIATRIC ONCOLOGY, 1991, 19 (02) :89-95
[8]   Orbital Cyst: Prenatal Diagnosis [J].
Singh, Arun D. ;
Traboulsi, Elias I. ;
Reid, Janet ;
Patno, Donna ;
Chapa, Jeffrey ;
Rodriguez, Ricardo ;
Iben, Sabine ;
Schoenfield, Lynn .
OPHTHALMOLOGY, 2009, 116 (10) :2042-2043